Ongoing monitoring required nbsp nbsp amiodarone TSH AST ALT q3 6mo ECG q1y CXR and physical exam for visual abnormalities skin changes neuro sx annually nbsp nbsp dofetilide ECG K Mg CrCl q3 6mo nbsp nbsp dronedarone ECG AST ALT w in first 6mo nbsp nbsp

Ongoing monitoring required:<br>
&nbsp;&nbsp;◦ amiodarone: TSH, AST, ALT (q3-6mo), ECG (q1y), CXR and physical exam for visual abnormalities, skin changes, neuro sx annually.<br>
&nbsp;&nbsp;◦ dofetilide: ECG, K+, Mg, CrCl q3-6mo.<br>
&nbsp;&nbsp;◦ dronedarone: ECG, AST, ALT w/in first 6mo.<br>
&nbsp;&nbsp;◦ procainamide: ECG, BP.<br>
&nbsp;&nbsp;◦ sotalol: ECG, K+, Mg, CrCl q3-6mo.<br><br>